Recombinant Mouse Mgat3 Protein ，His & Myc

Mgat3, or mannose-β-1,4-N-acetylglucosaminyltransferase 3, is a critical enzyme involved in the biosynthesis of N-glycans, which are essential glycoprotein structures that influence various biological processes, including cell signaling, immune response, and protein stability. The enzyme catalyzes the transfer of N-acetylglucosamine (GlcNAc) to mannose residues on glycoproteins, thus playing a significant role in the formation of complex N-glycan structures. Research into Mgat3 has gained importance due to its implications in diverse fields such as cancer biology, where altered N-glycosylation patterns are linked to tumor progression and metastasis. Furthermore, Mgat3 activity is associated with the modulation of the immune response; for instance, its expression can affect the binding affinity of glycoproteins to specific receptors, influencing cellular interactions. Understanding the structure and function of Mgat3, along with its regulatory mechanisms, can provide insights into therapeutic strategies for diseases characterized by aberrant glycosylation. In recent years, recombinant protein production of Mgat3 has become a valuable tool for studying its enzymatic properties and interactions, facilitating the development of potential inhibitors or modulators as therapeutic agents. Consequently, the study of Mgat3 not only enhances our knowledge of glycosylation biology but also paves the way for innovative approaches in treating glycan-related diseases.